111 related articles for article (PubMed ID: 32264202)
21. Tumor Acidic Microenvironment Targeted Drug Delivery Based on pHLIP-Modified Mesoporous Organosilica Nanoparticles.
Zhang Y; Dang M; Tian Y; Zhu Y; Liu W; Tian W; Su Y; Ni Q; Xu C; Lu N; Tao J; Li Y; Zhao S; Zhao Y; Yang Z; Sun L; Teng Z; Lu G
ACS Appl Mater Interfaces; 2017 Sep; 9(36):30543-30552. PubMed ID: 28809111
[TBL] [Abstract][Full Text] [Related]
22. Chemistry of Mesoporous Organosilica in Nanotechnology: Molecularly Organic-Inorganic Hybridization into Frameworks.
Chen Y; Shi J
Adv Mater; 2016 May; 28(17):3235-72. PubMed ID: 26936391
[TBL] [Abstract][Full Text] [Related]
23. Coordination-Accelerated "Iron Extraction" Enables Fast Biodegradation of Mesoporous Silica-Based Hollow Nanoparticles.
Wang L; Huo M; Chen Y; Shi J
Adv Healthc Mater; 2017 Nov; 6(22):. PubMed ID: 28941142
[TBL] [Abstract][Full Text] [Related]
24. "Manganese Extraction" Strategy Enables Tumor-Sensitive Biodegradability and Theranostics of Nanoparticles.
Yu L; Chen Y; Wu M; Cai X; Yao H; Zhang L; Chen H; Shi J
J Am Chem Soc; 2016 Aug; 138(31):9881-94. PubMed ID: 27441571
[TBL] [Abstract][Full Text] [Related]
25. Mesoporous organosilica nanoparticles with large radial pores via an assembly-reconstruction process in bi-phase.
Dang M; Li W; Zheng Y; Su X; Ma X; Zhang Y; Ni Q; Tao J; Zhang J; Lu G; Teng Z; Wang L
J Mater Chem B; 2017 Apr; 5(14):2625-2634. PubMed ID: 32264041
[TBL] [Abstract][Full Text] [Related]
26. Mesoporous Silica and Organosilica Nanoparticles: Physical Chemistry, Biosafety, Delivery Strategies, and Biomedical Applications.
Croissant JG; Fatieiev Y; Almalik A; Khashab NM
Adv Healthc Mater; 2018 Feb; 7(4):. PubMed ID: 29193848
[TBL] [Abstract][Full Text] [Related]
27. Cisplatin and doxorubicin high-loaded nanodrug based on biocompatible thioether- and ethane-bridged hollow mesoporous organosilica nanoparticles.
Zhang J; Weng L; Su X; Lu G; Liu W; Tang Y; Zhang Y; Wen J; Teng Z; Wang L
J Colloid Interface Sci; 2018 Mar; 513():214-221. PubMed ID: 29153715
[TBL] [Abstract][Full Text] [Related]
28. Hollow mesoporous hydroxyapatite nanoparticles (hmHANPs) with enhanced drug loading and pH-responsive release properties for intracellular drug delivery.
Yang YH; Liu CH; Liang YH; Lin FH; Wu KC
J Mater Chem B; 2013 May; 1(19):2447-2450. PubMed ID: 32261043
[TBL] [Abstract][Full Text] [Related]
29. Construction of homogenous/heterogeneous hollow mesoporous silica nanostructures by silica-etching chemistry: principles, synthesis, and applications.
Chen Y; Chen HR; Shi JL
Acc Chem Res; 2014 Jan; 47(1):125-37. PubMed ID: 23944328
[TBL] [Abstract][Full Text] [Related]
30. Biphasic Synthesis of Large-Pore and Well-Dispersed Benzene Bridged Mesoporous Organosilica Nanoparticles for Intracellular Protein Delivery.
Yang Y; Niu Y; Zhang J; Meka AK; Zhang H; Xu C; Lin CX; Yu M; Yu C
Small; 2015 Jun; 11(23):2743-9. PubMed ID: 25652950
[TBL] [Abstract][Full Text] [Related]
31. A comparison of mesoporous silica nanoparticles and mesoporous organosilica nanoparticles as drug vehicles for cancer therapy.
Yue J; Luo SZ; Lu MM; Shao D; Wang Z; Dong WF
Chem Biol Drug Des; 2018 Aug; 92(2):1435-1444. PubMed ID: 29671941
[TBL] [Abstract][Full Text] [Related]
32. Mesoporous organosilica hollow microspheres with hierarchical structures on the shell.
Zhang X; Liu T; Sun W; Liu J
J Nanosci Nanotechnol; 2013 Apr; 13(4):3046-53. PubMed ID: 23763199
[TBL] [Abstract][Full Text] [Related]
33. Facile synthesis of yolk-shell structured monodisperse mesoporous organosilica nanoparticles by a mild alkalescent etching approach.
Tao J; Dang M; Su X; Hao Q; Zhang J; Ma X; Lu G; Zhang Y; Tian Y; Weng L; Teng Z; Wang L
J Colloid Interface Sci; 2018 Oct; 527():33-39. PubMed ID: 29775819
[TBL] [Abstract][Full Text] [Related]
34. Core-Cone Structured Monodispersed Mesoporous Silica Nanoparticles with Ultra-large Cavity for Protein Delivery.
Xu C; Yu M; Noonan O; Zhang J; Song H; Zhang H; Lei C; Niu Y; Huang X; Yang Y; Yu C
Small; 2015 Nov; 11(44):5949-55. PubMed ID: 26426420
[TBL] [Abstract][Full Text] [Related]
35. Facile Synthesis of Yolk-Shell-Structured Triple-Hybridized Periodic Mesoporous Organosilica Nanoparticles for Biomedicine.
Teng Z; Zhang J; Li W; Zheng Y; Su X; Tang Y; Dang M; Tian Y; Yuwen L; Weng L; Lu G; Wang L
Small; 2016 Jul; 12(26):3550-8. PubMed ID: 27183872
[TBL] [Abstract][Full Text] [Related]
36. A versatile stimulus-responsive metal-organic framework for size/morphology tunable hollow mesoporous silica and pH-triggered drug delivery.
Zou Z; Li S; He D; He X; Wang K; Li L; Yang X; Li H
J Mater Chem B; 2017 Mar; 5(11):2126-2132. PubMed ID: 32263685
[TBL] [Abstract][Full Text] [Related]
37. Magnesium-Engineered Silica Framework for pH-Accelerated Biodegradation and DNAzyme-Triggered Chemotherapy.
Yu L; Chen Y; Lin H; Gao S; Chen H; Shi J
Small; 2018 Aug; 14(35):e1800708. PubMed ID: 30070076
[TBL] [Abstract][Full Text] [Related]
38. Deformable Hollow Periodic Mesoporous Organosilica Nanocapsules for Significantly Improved Cellular Uptake.
Teng Z; Wang C; Tang Y; Li W; Bao L; Zhang X; Su X; Zhang F; Zhang J; Wang S; Zhao D; Lu G
J Am Chem Soc; 2018 Jan; 140(4):1385-1393. PubMed ID: 29281272
[TBL] [Abstract][Full Text] [Related]
39. Fabrication of high specificity hollow mesoporous silica nanoparticles assisted by Eudragit for targeted drug delivery.
She X; Chen L; Velleman L; Li C; Zhu H; He C; Wang T; Shigdar S; Duan W; Kong L
J Colloid Interface Sci; 2015 May; 445():151-160. PubMed ID: 25617610
[TBL] [Abstract][Full Text] [Related]
40. Luminescent mesoporous nanoreservoirs for the effective loading and intracellular delivery of therapeutic drugs.
Kwon S; Singh RK; Kim TH; Patel KD; Kim JJ; Chrzanowski W; Kim HW
Acta Biomater; 2014 Mar; 10(3):1431-42. PubMed ID: 24239681
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
